Table 3:
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
Baseline characteristics | OR | 95% CI | P | OR | 95% CI | P |
Age (per 1 standard deviation) | 0.64 | 0.28–1.46 | .29 | 0.56 | 0.22–1.43 | .49 |
BMI (per 1 standard deviation) | 1.25 | 0.99–1.56 | .06 | 1.13 | 0.87–1.46 | .48 |
CKD stage | .001 | .14 | ||||
Stage 1–2 | 1.00 | Reference | ||||
Stage 3–5 | 3.23 | 1.67–6.28 | .001 | 2.07 | 0.73–5.83 | .14 |
Proteinuria | <.001 | <.001 | ||||
Group 1 | 1.00 | Reference | ||||
Group 2 | 5.87 | 2.63–13.10 | <.001 | 4.90 | 2.17–11.05 | <.001 |
Group 3 | 5.01 | 2.09–12.03 | <.001 | 4.41 | 1.82–10.69 | .001 |
Group 4 | 11.02 | 4.56–26.64 | <.001 | 9.90 | 4.05–24.23 | <.001 |
Group 5 | 48.22 | 16.15–144.01 | <.001 | 48.43 | 15.80–148.47 | <.001 |
MAP | <.001 | <.001 | ||||
<86.5 mmHg | 1.00 | Reference | ||||
≥86.5 mmHg | 3.07 | 1.83–5.15 | <.001 | 2.78 | 1.58–4.90 | <.001 |
Steroids/immunosuppressive therapy in early pregnancy (yes or no) | 1.89 | 1.06–3.37 | .03 | 1.03 | 0.53–2.03 | .78 |
Scr (per 1 standard deviation) | 1.40 | 1.14–1.72 | .002 | 0.95 | 0.71–1.28 | .41 |
Group 1: proteinuria <0.30 g/24 h; Group 2: 0.30 g/24 h ≤ proteinuria < 1.00 g/24 h; Group 3: 1.00 g/24 h ≤ proteinuria < 2.00 g/24 h; Group 4: 2.00 g/24 h ≤ proteinuria < 5.00 g/24 h; and Group 5: proteinuria ≥5.00 g/24 h.